Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer
Authors
Keywords
-
Journal
BJU INTERNATIONAL
Volume 122, Issue 1, Pages 50-58
Publisher
Wiley
Online
2018-02-01
DOI
10.1111/bju.14151
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS)
- (2018) Rita Faria et al. EUROPEAN UROLOGY
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
- (2017) Hashim U Ahmed et al. LANCET
- Two-Stage Biomarker Protocols for Improving the Precision of Early Detection of Prostate Cancer
- (2017) Christine L. Barnett et al. MEDICAL DECISION MAKING
- Cost-effectiveness of MR Imaging–guided Strategies for Detection of Prostate Cancer in Biopsy-Naive Men
- (2017) Shivani Pahwa et al. RADIOLOGY
- Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion–targeted Prostate Biopsy Outcomes
- (2016) Xiaosong Meng et al. EUROPEAN UROLOGY
- Magnetic Resonance and Ultrasound Image Fusion Supported Transperineal Prostate Biopsy Using the Ginsburg Protocol: Technique, Learning Points, and Biopsy Results
- (2016) Nienke Hansen et al. EUROPEAN UROLOGY
- Cost-effectiveness of culture-guided antimicrobial prophylaxis for the prevention of infections after prostate biopsy
- (2016) Chi-kong Li et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions
- (2016) M. Minhaj Siddiqui et al. JNCI-Journal of the National Cancer Institute
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
- (2016) Freddie C. Hamdy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic Value of Guided Biopsies: Fusion and Cognitive-registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate
- (2016) Daniel T. Oberlin et al. UROLOGY
- Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions
- (2016) M. Minhaj Siddiqui et al. JNCI-Journal of the National Cancer Institute
- Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies
- (2016) Joshua A. Roth et al. JAMA Oncology
- Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
- (2015) M. Minhaj Siddiqui et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the United States
- (2015) Ayal A. Aizer et al. Journal of the National Comprehensive Cancer Network
- Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer
- (2015) Jianyu Liu et al. UROLOGY
- Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI-RADS) scoring in a transperineal prostate biopsy setting
- (2014) Alistair D.R. Grey et al. BJU INTERNATIONAL
- Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data
- (2014) E. A. M. Heijnsdijk et al. JNCI-Journal of the National Cancer Institute
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- (2014) Fritz H Schröder et al. LANCET
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward Better Use of Bone Scans Among Men With Early-stage Prostate Cancer
- (2014) Selin Merdan et al. UROLOGY
- Clinical Predictors and Recommendations for Staging Computed Tomography Scan Among Men With Prostate Cancer
- (2014) Rachel Risko et al. UROLOGY
- Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis
- (2014) S. R. Willis et al. BMJ Open
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- Cost-effectiveness of Magnetic Resonance (MR) Imaging and MR-guided Targeted Biopsy Versus Systematic Transrectal Ultrasound–Guided Biopsy in Diagnosing Prostate Cancer: A Modelling Study from a Health Care Perspective
- (2013) Maarten de Rooij et al. EUROPEAN UROLOGY
- Early Detection of Prostate Cancer: AUA Guideline
- (2013) H. Ballentine Carter et al. JOURNAL OF UROLOGY
- ESUR prostate MR guidelines 2012
- (2012) Jelle O. Barentsz et al. EUROPEAN RADIOLOGY
- Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
- (2012) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Quality-of-Life Effects of Prostate-Specific Antigen Screening
- (2012) Eveline A.M. Heijnsdijk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis
- (2011) Mehrad Adibi et al. BJU INTERNATIONAL
- Projections of the Cost of Cancer Care in the United States: 2010-2020
- (2011) A. B. Mariotto et al. JNCI-Journal of the National Cancer Institute
- Complications After Prostate Biopsy: Data From SEER-Medicare
- (2011) Stacy Loeb et al. JOURNAL OF UROLOGY
- Calibrating disease progression models using population data: a critical precursor to policy development in cancer control
- (2010) R. Gulati et al. BIOSTATISTICS
- Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers
- (2010) Victor R. Grann et al. BREAST CANCER RESEARCH AND TREATMENT
- Empirical Estimates of the Lead Time Distribution for Prostate Cancer Based on Two Independent Representative Cohorts of Men Not Subject to Prostate-Specific Antigen Screening
- (2010) C. J. Savage et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005
- (2009) H. G. Welch et al. JNCI-Journal of the National Cancer Institute
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started